Joltoo
InvestorsInsights
DeepTech 2026 Playbook
Browse all
  1. Home
  2. /Investors
  3. /Synthetic Biology
  4. /CPT Capital
CPT Capital

CPT Capital

Pure DeepTechLondon, United KingdomActiveWebsite
Stage FocusSeed, Series A, Series B+
GeographyUS, Europe
TypeFamily Office
Last Activity2025
Industry Focus
Industries
Synthetic BiologyAgriTech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio

CPT Capital is the venture arm of a leading private family office and one of the pioneer investors in alternative protein — with arguably unmatched sector expertise. The portfolio of 58 investments includes 4 unicorns (Beyond Meat and Impossible Foods among them), 2 IPOs, and 4 acquisitions. They led ENOUGH's $43.5M Series B (mycoprotein technology) alongside HAL and Scottish Enterprise, demonstra...

Notable Investments
B
Beyond Meat
I
Impossible Foods
B
Bolt Threads
E
ENOUGH

Similar Funds

Flagship Pioneering

Flagship Pioneering

Cambridge, United States

Pure DeepTechSynthetic BiologyBiotechAgriTechPre-SeedSeed
Blue Horizon

Blue Horizon

Zurich, Switzerland

DeepTech NativeSynthetic BiologyAgriTechClimate TechSeedSeries A
Illumina Ventures

Illumina Ventures

San Diego, United States

Pure DeepTechSynthetic BiologyBiotechMedTechSeedSeries A
The Production Board

The Production Board

San Francisco, United States

Pure DeepTechSynthetic BiologyAgriTechBiotechPre-SeedSeed
Varana Capital

Varana Capital

Denver, United States

DeepTech NativeSynthetic BiologyAgriTechSeedSeries A
a16z Bio + Crypto (Andreessen Horowitz)

a16z Bio + Crypto (Andreessen Horowitz)

Menlo Park, United States

GeneralistSynthetic BiologyCrypto / Web3BiotechSeedSeries A
Joltoo
Privacy PolicyTerms of Service
© 2026 Joltoo. All rights reserved.